Additional file 5 of Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

Additional file 5. Original sequencing data including IHC type of all patients, SNVs, CNVs, and ctDNA fraction and bTMB of baseline plasma, SNVs and CNVs of plasma samples used for disease monitoring, and SNVs and CNVs of tissue samples. IHC, immunohistochemistry; SNVs, single nucleotide variations; CNVs, copy number variations; bTMB, blood-based tumor mutation burden.补充文件5。原始测序数据涵盖所有患者的免疫组化（immunohistochemistry, IHC）分型、基线血浆的单核苷酸变异（single nucleotide variations, SNVs）、拷贝数变异（copy number variations, CNVs）、循环肿瘤DNA（circulating tumor DNA, ctDNA）占比与基于血液的肿瘤突变负荷（blood-based tumor mutation burden, bTMB）、用于疾病监测的血浆样本的单核苷酸变异与拷贝数变异，以及组织样本的单核苷酸变异与拷贝数变异。